Acasti Pharma Balance Sheet - Annual (NASDAQ:ACST)

Add to My Stocks
$0.72 $0.03 (4%) ACST stock closing price Jun 22, 2018 (Closing)

The financial analysis of a company like Acasti Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. As in our Acasti Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The Acasti Pharma balance sheet for 2016 shows total assets of $16.27M. The company has a asset turnover ratio of -. Also see: Acasti Pharma revenue and Acasti Pharma operating cash flow for the same year.

View latest 10 year balance sheet data to check Acasti Pharma financial performance.
show more
Fiscal year is Jan - Dec2016201520142013
Cash1.36M3.59M1.63M2.72M
Marketable Securities3.03M7.08M15.92M-
Receivables----
Inventory----
Raw Materials----
Work In Progress----
Finished Goods----
Notes Receivable----
Other Current Assets----
Total Current Assets
4.65M11.2M18.67M5.11M
Property Plant & Equipment----
Accumulated Depreciation----
Net Property Plant & Equipment
1.69M---
Investment & Advances----
Other Non-Current Assets----
Deferred Charges----
Intangibles9.92M11.99M16.16M19.4M
Deposits & Other Assets----
Total Assets
16.27M23.43M34.9M24.53M
Notes Payable----
Accounts Payable1.31M1.2M1.12M2.06M
Current Portion Long-Term Debt----
Current Portion Capital Leases----
Accrued Expenses----
Income Taxes Payable----
Other Current Liabilities---2.71M
Total Current Liabilities
1.32M1.23M1.76M4.78M
Mortgages----
Deferred Taxes/Income----
Convertible Debt----
Long-Term Debt----
Non-Current Capital Leases----
Other Long-Term Liabilities--1.48M-
Total Liabilities
1.37M1.43M3.24M4.78M
Minority Interest----
Preferred Stock----
Common Stock Net46.7M46.87M54.91M44.63M
Capital Surplus3.99M3.69M4.12M2.71M
Retained Earnings-35.8M-28.57M-27.74M-27.99M
Treasury Stock----
Other Liabilities----
Shareholders Equity14.9M21.99M31.66M19.74M
Total Liabilities & Shareholders Equity16.27M23.43M34.9M24.53M
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Acasti Pharma stock price, and Acasti Pharma historical stock prices show the stock price movement over time, and the Acasti Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Acasti Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ACST stock as of 2016 is $16.27M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Acasti Pharma for the year 2016 total to $1.37M. Liabilities for a company like Acasti Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Acasti Pharma Balance Sheet - Key Ratios

Current ratio
0
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0